91精品国产综合久久香蕉的用户体验_震车做爰的视频|HD中文字幕在线播放,久久精品8,天天躁日日躁狠狠躁免费麻豆 ,性一交一性一交肉体

  • 新聞與活動(dòng)

    學(xué)術(shù)成果

Computational Modeling of the Disulfide Cross-Linking Reaction

J. Phys. Chem. B 2020, 124, 44, 9840–9851

Disulfide cross-linking is one of the fundamental covalent bonds that exist prevalently in many biological molecules that is involved in versatile functional activities such as antibody stability, viral assembly, and protein folding. Additionally, it is a crucial factor in various industrial applications. Therefore, a fundamental understanding of its reaction mechanism would help gain insight into its different functional activities. Computational simulation of the disulfide cross-linking reaction with hydrogen peroxide (H2O2) was performed at the integrated quantum mechanical/molecular mechanical (QM/MM) level of theory in a water box under periodic boundary conditions. A benchmarking study for the barrier height of the disulfide formation step was performed on a model system between methanethiol and methane sulfenic acid to determine, for the QM system, the best-fit density functional theory (DFT) functional/basis set combination that produces comparable results to a higher-level theory of the coupled-cluster method. Computational results show that the disulfide cross-linking reaction with H2O2 reagent can proceed through a one-step or a two-step pathway for the high pKa cysteines or two different pathways for the low pKa cysteines to ultimately produce the sulfenic acid/sulfenate intermediate complex. Subsequently, those intermediates react with another neutral/anionic cysteine residue to form the cysteine product. In addition, the solvent-assisted proton-exchange/proton-transfer effects were examined on the energetic barriers for the different transition states, and the molecular contributions of the chemically involved water molecules were studied in detail.

想繼續(xù)了解更多?

聯(lián)系我們

我們期待您的留言

讓我們知道如何為您提供幫助,我們團(tuán)隊(duì)將24小時(shí)內(nèi)與您聯(lián)系!

姓名
電話
郵箱
國(guó)家/地區(qū)
北京市
天津市
上海市
重慶市
河北省
山西省
遼寧省
吉林省
黑龍江省
江蘇省
浙江省
安徽省
福建省
江西省
山東省
河南省
湖北省
湖南省
廣東省
海南省
四川省
貴州省
云南省
陜西省
甘肅省
青海省
臺(tái)灣省
內(nèi)蒙古自治區(qū)
廣西壯族自治區(qū)
西藏自治區(qū)
寧夏回族自治區(qū)
新疆維吾爾自治區(qū)
香港特別行政區(qū)
澳門特別行政區(qū)
從事行業(yè)
小分子藥物研發(fā)
抗體藥物研發(fā)
CRO/CDMO
投融資機(jī)構(gòu)
高校/研究院所/醫(yī)院
園區(qū)
生物醫(yī)藥產(chǎn)業(yè)
感興趣的業(yè)務(wù)
小分子藥物發(fā)現(xiàn)
抗體藥物發(fā)現(xiàn)
藥物固體形態(tài)研發(fā)
化學(xué)合成服務(wù)(含自動(dòng)化合成)
實(shí)驗(yàn)室自動(dòng)化解決方案
所在公司
是否需要業(yè)務(wù)人員跟進(jìn)?
暫不需要
驗(yàn)證碼

我已閱讀并同意 晶泰科技隱私政策法律聲明